|
1
|
Chi H, Pepper M and Thomas PG: Principles
and therapeutic applications of adaptive immunity. Cell.
187:2052–2078. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rastogi I, Jeon D, Moseman JE, Muralidhar
A, Potluri HK and McNeel DG: Role of B cells as antigen presenting
cells. Front Immunol. 13:9549362022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mauri C and Bosma A: Immune regulatory
function of B cells. Annu Rev Immunol. 30:221–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cyster JG and Allen CDC: B cell responses:
cell interaction dynamics and decisions. Cell. 177:524–540. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barnas JL, Looney RJ and Anolik JH: B cell
targeted therapies in autoimmune disease. Curr Opin Immunol.
61:92–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carter LM, Ehrenstein MR and Vital EM:
Evolution and trajectory of B-cell targeted therapies in rheumatic
diseases. Lancet Rheumatol. 7:e355–e367. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ronco P, Beck L, Debiec H, Fervenza FC,
Hou FF, Jha V, Sethi S, Tong A, Vivarelli M and Wetzels J:
Membranous nephropathy. Nat Rev Dis Primers. 7:692021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Liu J, Burrows PD and Wang JY: B
cell development and maturation. Adv Exp Med Biol. 1254:1–22. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghosn E, Yoshimoto M, Nakauchi H, Weissman
IL and Herzenberg LA: Hematopoietic stem cell-independent
hematopoiesis and the origins of innate-like B lymphocytes.
Development. 146:dev1705712019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Liao S, Xiao Z and Pan Q, Wang X,
Shen K, Wang S, Yang L, Guo F, Liu HF and Pan Q: The development
and improvement of immunodeficient mice and humanized immune system
mouse models. Front Immunol. 13:10075792022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonaud A, Lemos JP, Espéli M and
Balabanian K: Hematopoietic multipotent progenitors and plasma
cells: Neighbors or roommates in the mouse bone marrow ecosystem?
Front Immunol. 12:6585352021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rumfelt LL, Zhou Y, Rowley BM, Shinton SA
and Hardy RR: Lineage specification and plasticity in CD19- early B
cell precursors. J Exp Med. 203:675–687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luc S, Buza-Vidas N and Jacobsen SE:
Biological and molecular evidence for existence of lymphoid-primed
multipotent progenitors. Ann N Y Acad Sci. 1106:89–94. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zandi S, Mansson R, Tsapogas P, Zetterblad
J, Bryder D and Sigvardsson M: EBF1 is essential for B-lineage
priming and establishment of a transcription factor network in
common lymphoid progenitors. J Immunol. 181:3364–3372. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Otero DC and Rickert RC: CD19 function in
early and late B cell development. II. CD19 facilitates the
pro-B/pre-B transition. J Immunol. 171:5921–5930. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pieper K, Grimbacher B and Eibel H: B cell
biology and development. J Allergy Clin Immunol. 131:959–971. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jimi E, Phillips RJ, Rincon M, Voll R,
Karasuyama H, Flavell R and Ghosh S: Activation of NF-kappaB
promotes the transition of large, CD43+ pre-B cells to small, CD43-
pre-B cells. Int Immunol. 17:815–825. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Claudio E, Saret S, Wang H and Siebenlist
U: Cell-autonomous role for NF-kappa B in immature bone marrow B
cells. J Immunol. 182:3406–3413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malin S, McManus S, Cobaleda C,
Novatchkova M, Delogu A, Bouillet P, Strasser A and Busslinger M:
Role of STAT5 in controlling cell survival and immunoglobulin gene
recombination during pro-B cell development. Nat Immunol.
11:171–179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Giltiay NV, Giordano D and Clark EA: The
plasticity of newly formed B cells. J Immunol. 203:3095–3104. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mårtensson IL, Keenan RA and Licence S:
The pre-B cell receptor. Curr Opin Immunol. 19:137–142. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bot A: Immunoglobulin deficient mice
generated by gene targeting as models for studying the immune
response. Int Rev Immunol. 13:327–340. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nemazee D: Mechanisms of central tolerance
for B cells. Nat Rev Immunol. 17:281–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsubata T: B cell tolerance and
autoimmunity. F1000Res. 6:3912017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
King LB and Monroe JG: Immunobiology of
the immature B cell: Plasticity in the B-cell antigen
receptor-induced response fine tunes negative selection. Immunol
Rev. 176:86–104. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Johnson JL, Scholz JL, Marshak-Rothstein A
and Cancro MP: Molecular pattern recognition in peripheral B cell
tolerance: lessons from age-associated B cells. Curr Opin Immunol.
61:33–38. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Y, Zhang Y, Han J, Yang M, Zhu J and
Jin T: Transitional B cells involved in autoimmunity and their
impact on neuroimmunological diseases. J Transl Med. 18:1312020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Benitez A, Weldon AJ, Tatosyan L, Velkuru
V, Lee S, Milford TA, Francis OL, Hsu S, Nazeri K, Casiano CM, et
al: Differences in mouse and human nonmemory B cell pools. J
Immunol. 192:4610–4619. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yeramilli VA and Knight KL: Somatically
diversified and proliferating transitional B cells: Implications
for peripheral B cell homeostasis. J Immunol. 186:6437–6444. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dieudonné Y, Gies V, Guffroy A, Keime C,
Bird AK, Liesveld J, Barnas JL, Poindron V, Douiri N,
Soulas-Sprauel P, et al: Transitional B cells in quiescent SLE: An
early checkpoint imprinted by IFN. J Autoimmun. 102:150–158. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lechner M, Engleitner T, Babushku T,
Schmidt-Supprian M, Rad R, Strobl LJ and Zimber-Strobl U:
Notch2-mediated plasticity between marginal zone and follicular B
cells. Nat Commun. 12:11112021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Smulski CR and Eibel H: BAFF and
BAFF-receptor in B cell selection and survival. Front Immunol.
9:22852018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gorelik L, Gilbride K, Dobles M, Kalled
SL, Zandman D and Scott ML: Normal B cell homeostasis requires B
cell activation factor production by radiation-resistant cells. J
Exp Med. 198:937–945. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song H and Cerny J: Functional
heterogeneity of marginal zone B cells revealed by their ability to
generate both early antibody-forming cells and germinal centers
with hypermutation and memory in response to a T-dependent antigen.
J Exp Med. 198:1923–1935. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tay C, Liu YH, Kanellakis P, Kallies A, Li
Y, Cao A, Hosseini H, Tipping P, Toh BH, Bobik A and Kyaw T:
Follicular B cells promote atherosclerosis via T cell-mediated
differentiation into plasma cells and secreting pathogenic
immunoglobulin G. Arterioscler Thromb Vasc Biol. 38:e71–e84. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Young C and Brink R: The unique biology of
germinal center B cells. Immunity. 54:1652–1664. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lebecque S, de Bouteiller O, Arpin C,
Banchereau J and Liu YJ: Germinal center founder cells display
propensity for apoptosis before onset of somatic mutation. J Exp
Med. 185:563–571. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cook MC: B cell biology, apoptosis, and
autoantibodies to phospholipids. Thromb Res. 114:307–319. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eeva J and Pelkonen J: Mechanisms of B
cell receptor induced apoptosis. Apoptosis. 9:525–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thoreau B, Chaigne B and Mouthon L: Role
of B cell in the pathogenesis of systemic sclerosis. Front Immunol.
13:9334682022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Inoue T, Moran I, Shinnakasu R, Phan TG
and Kurosaki T: Generation of memory B cells and their
reactivation. Immunol Rev. 283:138–149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Inoue T, Shinnakasu R and Kurosaki T:
Generation of high quality memory B cells. Front Immunol.
12:8258132022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tanaka S and Baba Y: B cell receptor
signaling. Adv Exp Med Biol. 1254:23–36. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hardy RR and Hayakawa K: B cell
development pathways. Annu Rev Immunol. 19:595–621. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yoshimoto M: The ontogeny of murine B-1a
cells. Int J Hematol. 111:622–627. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hayakawa K and Hardy RR: Development and
function of B-1 cells. Curr Opin Immunol. 12:346–353. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li YS, Hayakawa K and Hardy RR: The
regulated expression of B lineage associated genes during B cell
differentiation in bone marrow and fetal liver. J Exp Med.
178:951–960. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Holodick NE, Vizconde T and Rothstein TL:
B-1a cell diversity: Nontemplated addition in B-1a cell Ig is
determined by progenitor population and developmental location. J
Immunol. 192:2432–2441. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Juszczyński P, Nowak J and Warzocha K:
Host immune response in B cell lymphomas: friend or foe? Arch
Immunol Ther Exp (Warsz). 56:245–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dong Z, Liu Z, Dai H, Liu W, Feng Z, Zhao
Q, Gao Y, Liu F, Zhang N, Dong X, et al: The potential role of
regulatory B cells in idiopathic membranous nephropathy. J Immunol
Res. 2020:76383652020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Piatelli M, Tanguay D, Rothstein T and
Chiles T: Cell cycle control mechanisms in B-1 and B-2 lymphoid
subsets. Immunol Res. 27:31–52. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hardy RR: B-1 B cell development. J
Immunol. 177:2749–2754. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Novaes E, Brito RR, Dos Santos Toledo M,
Labussiere GM, Dupin TV, de Campos Reis NF, Perez EC and Xander P:
B-1 cell response in immunity against parasites. Parasitol Res.
118:1343–1352. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tung JW and Herzenberg LA: Unraveling B-1
progenitors. Curr Opin Immunol. 19:150–155. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Slack E, Balmer ML and Macpherson AJ: B
cells as a critical node in the microbiota-host immune system
network. Immunol Rev. 260:50–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Osugui L, de Roo JJ, de Oliveira VC, Sodré
ACP, Staal FJT and Popi AF: B-1 cells and B-1 cell precursors
prompt different responses to Wnt signaling. PLoS One.
13:e01993322018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Rosser EC and Mauri C: Regulatory B cells:
Origin, phenotype, and function. Immunity. 42:607–612. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Alhakeem SS, Sindhava VJ, McKenna MK,
Gachuki BW, Byrd JC, Muthusamy N and Bondada S: Role of B cell
receptor signaling in IL-10 production by normal and malignant B-1
cells. Ann N Y Acad Sci. 1362:239–249. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang Y, Zhu G, Xiao H, Liu X, Han G, Chen
G, Hou C, Shen B, Li Y, Ma N and Wang R: CD19 regulates
ADAM28-mediated Notch2 cleavage to control the differentiation of
marginal zone precursors to MZ B cells. J Cell Mol Med.
21:3658–3669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Barátki BL, Huber K, Sármay G, Matkó J and
Kövesdi D: Inflammatory signal induced IL-10 production of marginal
zone B-cells depends on CREB. Immunol Lett. 212:14–21. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu D, Yin X, Olyha SJ, Nascimento MSL,
Chen P, White T, Gowthaman U, Zhang T, Gertie JA, Zhang B, et al:
IL-10-dependent crosstalk between murine marginal zone B cells,
macrophages, and CD8α+ dendritic cells promotes listeria
monocytogenes infection. Immunity. 51:64–76.e7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Bommer I, Muzzio DO, Zygmunt M and Jensen
F: Progesterone and estradiol exert an inhibitory effect on the
production of anti-inflammatory cytokine IL-10 by activated MZ B
cells. J Reprod Immunol. 116:113–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Matsumoto M, Baba A, Yokota T, Nishikawa
H, Ohkawa Y, Kayama H, Kallies A, Nutt SL, Sakaguchi S, Takeda K,
et al: Interleukin-10-producing plasmablasts exert regulatory
function in autoimmune inflammation. Immunity. 41:1040–1051. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
van de Veen W, Stanic B, Wirz OF, Jansen
K, Globinska A and Akdis M: Role of regulatory B cells in immune
tolerance to allergens and beyond. J Allergy Clin Immunol.
138:654–665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Jansen K, Cevhertas L, Ma S, Satitsuksanoa
P, Akdis M and van de Veen W: Regulatory B cells, A to Z. Allergy.
76:2699–2715. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Catalán D, Mansilla MA, Ferrier A, Soto L,
Oleinika K, Aguillón JC and Aravena O: Immunosuppressive mechanisms
of regulatory B cells. Front Immunol. 12:6117952021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang RX, Yu CR, Dambuza IM, Mahdi RM,
Dolinska MB, Sergeev YV, Wingfield PT, Kim SH and Egwuagu CE:
Interleukin-35 induces regulatory B cells that suppress autoimmune
disease. Nat Med. 20:633–641. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Romero-Ramírez S, Navarro-Hernandez IC,
Cervantes-Díaz R, Sosa-Hernández VA, Acevedo-Ochoa E,
Kleinberg-Bild A, Valle-Rios R, Meza-Sánchez DE,
Hernández-Hernández JM and Maravillas-Montero JL: Innate-like B
cell subsets during immune responses: Beyond antibody production. J
Leukoc Biol. 105:843–856. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Palm AE and Kleinau S: Marginal zone B
cells: From housekeeping function to autoimmunity? J Autoimmun.
119:1026272021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Dubreil L, Ledevin M, Hervet C, Menard D,
Philippe C, Michel FJ, Larcher T, Meurens F and Bertho N: The
internal conduit system of the swine inverted lymph node. Front
Immunol. 13:8693842022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Phan TG, Green JA, Gray EE, Xu Y and
Cyster JG: Immune complex relay by subcapsular sinus macrophages
and noncognate B cells drives antibody affinity maturation. Nat
Immunol. 10:786–793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Moran I, Grootveld AK, Nguyen A and Phan
TG: Subcapsular sinus macrophages: The seat of innate and adaptive
memory in murine lymph nodes. Trends Immunol. 40:35–48. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tay C, Kanellakis P, Hosseini H, Cao A,
Toh BH, Bobik A and Kyaw T: B cell and CD4 T cell interactions
promote development of atherosclerosis. Front Immunol. 10:30462020.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Maddur MS, Sharma M, Hegde P,
Stephen-Victor E, Pulendran B, Kaveri SV and Bayry J: Human B cells
induce dendritic cell maturation and favour Th2 polarization by
inducing OX-40 ligand. Nat Commun. 5:40922014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ise W and Kurosaki T: Regulation of plasma
cell differentiation. Adv Exp Med Biol. 1254:63–74. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Shinnakasu R and Kurosaki T: Regulation of
memory B and plasma cell differentiation. Curr Opin Immunol.
45:126–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Horns F, Vollmers C, Croote D, Mackey SF,
Swan GE, Dekker CL, Davis MM and Quake SR: Lineage tracing of human
B cells reveals the in vivo landscape of human antibody class
switching. Elife. 5:e165782016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Chi X, Li Y and Qiu X: V(D)J
recombination, somatic hypermutation and class switch recombination
of immunoglobulins: mechanism and regulation. Immunology.
160:233–247. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Li G, Zan H, Xu Z and Casali P:
Epigenetics of the antibody response. Trends Immunol. 34:460–470.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Durham SR and Penagos M: Sublingual or
subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin
Immunol. 137:339–349.e10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Kim EH, Yang L, Ye P, Guo R, Li Q, Kulis
MD and Burks AW: Long-term sublingual immunotherapy for peanut
allergy in children: Clinical and immunologic evidence of
desensitization. J Allergy Clin Immunol. 144:1320–1326.e1. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Figo DD, Cordeiro Macedo PR, Gadermaier G,
Remuzgo C, Castro FFM, Kalil J, Galvão CES and Santos KS: IgE and
IgG4 epitopes of dermatophagoides and blomia allergens before and
after sublingual immunotherapy. Int J Mol Sci. 24:41732023.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Heeringa JJ, McKenzie CI, Varese N, Hew M,
Bakx ATCM, Aui PM, Rolland JM, O'Hehir RE and van Zelm MC:
Induction of IgG2 and IgG4 B-cell memory
following sublingual immunotherapy for ryegrass pollen allergy.
Allergy. 75:1121–1132. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Fujieda S, Lin YQ, Saxon A and Zhang K:
Multiple types of chimeric germ-line Ig heavy chain transcripts in
human B cells: Evidence for trans-splicing of human Ig RNA. J
Immunol. 157:3450–3459. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Abd El-Aleem SA, Saber EA, Aziz NM,
El-Sherif H, Abdelraof AM and Djouhri L: Follicular dendritic
cells. J Cell Physiol. 237:2019–2033. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Rezk SA, Nathwani BN, Zhao X and Weiss LM:
Follicular dendritic cells: Origin, function, and different
disease-associated patterns. Hum Pathol. 44:937–950. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Laidlaw BJ and Cyster JG: Transcriptional
regulation of memory B cell differentiation. Nat Rev Immunol.
21:209–220. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Mayer CT, Gazumyan A, Kara EE, Gitlin AD,
Golijanin J, Viant C, Pai J, Oliveira TY, Wang Q, Escolano A, et
al: The microanatomic segregation of selection by apoptosis in the
germinal center. Science. 358:eaao26022017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Stewart I, Radtke D, Phillips B, McGowan
SJ and Bannard O: Germinal center B cells replace their antigen
receptors in dark zones and fail light zone entry when
immunoglobulin gene mutations are damaging. Immunity.
49:477–489.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kuo TC, Shaffer AL, Haddad J Jr, Choi YS,
Staudt LM and Calame K: Repression of BCL-6 is required for the
formation of human memory B cells in vitro. J Exp Med. 204:819–830.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Suan D, Kräutler NJ, Maag JLV, Butt D,
Bourne K, Hermes JR, Avery DT, Young C, Statham A, Elliott M, et
al: CCR6 defines memory B cell precursors in mouse and human
germinal centers, revealing light-zone location and predominant low
antigen affinity. Immunity. 47:1142–1153.e4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Laidlaw BJ, Schmidt TH, Green JA, Allen
CD, Okada T and Cyster JG: The Eph-related tyrosine kinase ligand
Ephrin-B1 marks germinal center and memory precursor B cells. J Exp
Med. 214:639–649. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ise W, Fujii K, Shiroguchi K, Ito A,
Kometani K, Takeda K, Kawakami E, Yamashita K, Suzuki K, Okada T
and Kurosaki T: T follicular helper cell-germinal center B cell
interaction strength regulates entry into plasma cell or recycling
germinal center cell fate. Immunity. 48:702–715.e4. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Radtke D and Bannard O: Expression of the
plasma cell transcriptional regulator blimp-1 by dark zone germinal
center B cells during periods of proliferation. Front Immunol.
9:31062019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Nakagawa R, Toboso-Navasa A, Schips M,
Young G, Bhaw-Rosun L, Llorian-Sopena M, Chakravarty P, Sesay AK,
Kassiotis G, Meyer-Hermann M and Calado DP: Permissive selection
followed by affinity-based proliferation of GC light zone B cells
dictates cell fate and ensures clonal breadth. Proc Natl Acad Sci
USA. 118:e20164251182021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Huang C: Germinal center reaction. Adv Exp
Med Biol. 1254:47–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Kumar A, Priya A, Ahmed T, Grundström C,
Negi N and Grundström T: Regulation of the DNA repair complex
during somatic hypermutation and class-switch recombination. J
Immunol. 200:4146–4156. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Silver J, Zuo T, Chaudhary N, Kumari R,
Tong P, Giguere S, Granato A, Donthula R, Devereaux C and Wesemann
DR: Stochasticity enables BCR-independent germinal center
initiation and antibody affinity maturation. J Exp Med. 215:77–90.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Yeap LS and Meng FL: Cis- and
trans-factors affecting AID targeting and mutagenic outcomes in
antibody diversification. Adv Immunol. 141:51–103. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Inoue T and Kurosaki T: Memory B cells.
Nat Rev Immunol. 24:5–17. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Cancro MP and Tomayko MM: Memory B cells
and plasma cells: The differentiative continuum of humoral
immunity. Immunol Rev. 303:72–82. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Elsner RA and Shlomchik MJ: Germinal
center and extrafollicular B cell responses in vaccination,
immunity, and autoimmunity. Immunity. 53:1136–1150. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Ise W and Kurosaki T: Plasma cell
differentiation during the germinal center reaction. Immunol Rev.
288:64–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Wu H, Deng Y, Feng Y, Long D, Ma K, Wang
X, Zhao M, Lu L and Lu Q: Epigenetic regulation in B cell
maturation and its dysregulation in autoimmunity. Cell Mol Immunol.
15:676–684. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Yu K: AID function in somatic
hypermutation and class switch recombination. Acta Biochim Biophys
Sin (Shanghai). 54:759–766. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Elias C, Chen C and Cherukuri A:
Regulatory B cells in solid organ transplantation: From immune
monitoring to immunotherapy. Transplantation. 108:1080–1089. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Cherukuri A and Rothstein DM: Regulatory
and transitional B cells: Potential biomarkers and therapeutic
targets in organ transplantation. Curr Opin Organ Transplant.
27:385–391. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Zhang Y, Wang W, Liu Q, Jiang J, Zhao P,
Huang C, Li Y and Fu Y: CD19+CD73+ B cells
infiltration indicates poor prognosis and unfavorable responses to
immunotherapy in gastric cancer. Int Immunopharmacol.
141:1130022024. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Veh J, Ludwig C, Schrezenmeier H and
Jahrsdörfer B: Regulatory B cells-immunopathological and prognostic
potential in humans. Cells. 13:3572024. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Zhou CJ, Xie BL, Han HY, Wang Y, Wang YH,
Hong JY, Wei YX, Liu ZG, Feng Y, Yang G and Yang PC: Short-chain
fatty acids promote immunotherapy by modulating immune regulatory
property in B cells. J Immunol Res. 2021:26843612021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Caielli S, Wan Z and Pascual V: Systemic
lupus erythematosus pathogenesis: Interferon and beyond. Annu Rev
Immunol. 41:533–560. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Anders HJ, Saxena R, Zhao MH, Parodis I,
Salmon JE and Mohan C: Lupus nephritis. Nat Rev Dis Primers.
6:72020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Zhang Y, Tian J, Xiao F, Zheng L, Zhu X,
Wu L, Zhao C, Wang S, Rui K, Zou H and Lu L: B cell-activating
factor and its targeted therapy in autoimmune diseases. Cytokine
Growth Factor Rev. 64:57–70. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Arbitman L, Furie R and Vashistha H: B
cell-targeted therapies in systemic lupus erythematosus. J
Autoimmun. 132:1028732022. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Chang A, Clark MR and Ko K: Cellular
aspects of the pathogenesis of lupus nephritis. Curr Opin
Rheumatol. 33:197–204. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Jiang N, Jin S, Yu C, Zhao J, Wang Q, Tian
X, Li M and Zeng X: Efficacy and safety of immunosuppressive agents
for adults with lupus nephritis: a systematic review and network
meta-analysis. Front Immunol. 14:12322442023. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Palmer SC, Tunnicliffe DJ, Singh-Grewal D,
Mavridis D, Tonelli M, Johnson DW, Craig JC, Tong A and Strippoli
GFM: Induction and maintenance immunosuppression treatment of
proliferative lupus nephritis: A network meta-analysis of
randomized trials. Am J Kidney Dis. 70:324–336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Duxbury B, Combescure C and Chizzolini C:
Rituximab in systemic lupus erythematosus: An updated systematic
review and meta-analysis. Lupus. 22:1489–1503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Dooley MA, Houssiau F, Aranow C, D'Cruz
DP, Askanase A, Roth DA, Zhong ZJ, Cooper S, Freimuth WW and
Ginzler EM; BLISS-52-76 Study Groups, : Effect of belimumab
treatment on renal outcomes: results from the phase 3 belimumab
clinical trials in patients with SLE. Lupus. 22:63–72. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Yap DYH and Chan TM: B cell abnormalities
in systemic lupus erythematosus and lupus nephritis-role in
pathogenesis and effect of immunosuppressive treatments. Int J Mol
Sci. 20:62312019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Almaani S and Rovin BH: B cell therapy in
lupus nephritis: An overview. Nephrol Dial Transplant. 34:22–29.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Cassia M, Alberici F, Gallieni M and Jayne
D: Lupus nephritis and B cell targeting therapy. Expert Rev Clin
Immunol. 13:951–962. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Sekine H, Watanabe H and Gilkeson GS:
Enrichment of anti-glomerular antigen antibody-producing cells in
the kidneys of MRL/MpJ-Fas(lpr) mice. J Immunol. 172:3913–3921.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Espeli M, Bökers S, Giannico G, Dickinson
HA, Bardsley V, Fogo AB and Smith KG: Local renal autoantibody
production in lupus nephritis. J Am Soc Nephrol. 22:296–305. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Marinov AD, Wang H, Bastacky SI, van
Puijenbroek E, Schindler T, Speziale D, Perro M, Klein C, Nickerson
KM and Shlomchik MJ: The type II anti-CD20 antibody obinutuzumab
(GA101) is more effective than rituximab at depleting B cells and
treating disease in a murine lupus model. Arthritis Rheumatol.
73:826–836. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Neubert K, Meister S, Moser K, Weisel F,
Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA and
Voll RE: The proteasome inhibitor bortezomib depletes plasma cells
and protects mice with lupus-like disease from nephritis. Nat Med.
14:748–755. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
127
|
Ichikawa HT, Conley T, Muchamuel T, Jiang
J, Lee S, Owen T, Barnard J, Nevarez S, Goldman BI, Kirk CJ, et al:
Beneficial effect of novel proteasome inhibitors in murine lupus
via dual inhibition of type I interferon and autoantibody-secreting
cells. Arthritis Rheum. 64:493–503. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Seavey MM, Lu LD, Stump KL, Wallace NH and
Ruggeri BA: Novel, orally active, proteasome inhibitor, delanzomib
(CEP-18770), ameliorates disease symptoms and glomerulonephritis in
two preclinical mouse models of SLE. Int Immunopharmacol.
12:257–270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Shlomchik MJ, Madaio MP, Ni D, Trounstein
M and Huszar D: The role of B cells in lpr/lpr-induced
autoimmunity. J Exp Med. 180:1295–1306. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Chan OT, Hannum LG, Haberman AM, Madaio MP
and Shlomchik MJ: A novel mouse with B cells but lacking serum
antibody reveals an antibody-independent role for B cells in murine
lupus. J Exp Med. 189:1639–1648. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Yu C, Chen S, Zhou B, Zhang H, Su X, Luo Y
and Yang L: A novel BAFF antagonist, BAFF-Trap, effectively
alleviates the disease progression of systemic lupus erythematosus
in MRL/lpr mice. Mol Immunol. 129:1–11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Kayagaki N, Yan M, Seshasayee D, Wang H,
Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, et al:
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand
through a discrete surface loop and promotes processing of
NF-kappaB2. Immunity. 17:515–524. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Ma K, Du W, Wang X, Yuan S, Cai X, Liu D,
Li J and Lu L: Multiple functions of B cells in the pathogenesis of
systemic lupus erythematosus. Int J Mol Sci. 20:60212019.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Bruhns P and Jönsson F: Mouse and human
FcR effector functions. Immunol Rev. 268:25–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Dekkers G, Bentlage AEH, Stegmann TC,
Howie HL, Lissenberg-Thunnissen S, Zimring J, Rispens T and
Vidarsson G: Affinity of human IgG subclasses to mouse Fc gamma
receptors. MAbs. 9:767–773. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Meffre E and O'Connor KC: Impaired B-cell
tolerance checkpoints promote the development of autoimmune
diseases and pathogenic autoantibodies. Immunol Rev. 292:90–101.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Talaat RM, Mohamed SF, Bassyouni IH and
Raouf AA: Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus
erythematosus (SLE) patients: Correlation with disease activity.
Cytokine. 72:146–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Shapouri-Moghaddam A, Mohammadian S,
Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi
A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization,
and function in health and disease. J Cell Physiol. 233:6425–6440.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Zhao Q, Dai H, Liu X, Jiang H, Liu W, Feng
Z, Zhang N, Gao Y, Dong Z, Zhou X, et al: Helper T cells in
idiopathic membranous nephropathy. Front Immunol. 12:6656292021.
View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Deng B, Deng L, Liu M, Zhao Z, Huang H, Tu
X, Liang E, Tian R, Wang X, Wang R, et al: Elevated circulating
CD19+CD24hiCD38hi B cells display
pro-inflammatory phenotype in idiopathic membranous nephropathy.
Immunol Lett. 261:58–65. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Ramachandran R, Kaundal U, Girimaji N,
Rakha A, Rathi M, Gupta KL, Kohli HS and Jha V: Regulatory B cells
are reduced and correlate with disease activity in primary
membranous nephropathy. Kidney Int Rep. 5:872–878. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Ginzler EM, Wax S, Rajeswaran A, Copt S,
Hillson J, Ramos E and Singer NG: Atacicept in combination with MMF
and corticosteroids in lupus nephritis: Results of a prematurely
terminated trial. Arthritis Res Ther. 14:R332012. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Gauckler P, Shin JI, Alberici F, Audard V,
Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K,
et al: Rituximab in membranous nephropathy. Kidney Int Rep.
6:881–893. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Maritati F, Peyronel F and Vaglio A:
IgG4-related disease: A clinical perspective. Rheumatology
(Oxford). 59 (Suppl 3):iii123–iii131. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Barrett C, Willcocks LC, Jones RB, Tarzi
RM, Henderson RB, Cai G, Gisbert SI, Belson AS and Savage CO:
Effect of belimumab on proteinuria and anti-phospholipase A2
receptor autoantibody in primary membranous nephropathy. Nephrol
Dial Transplant. 35:599–606. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Heesters BA, van der Poel CE, Das A and
Carroll MC: Antigen presentation to B cells. Trends Immunol.
37:844–854. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Costa BA, Ortiz RJ, Lesokhin AM and
Richter J: Soluble B cell maturation antigen in multiple myeloma.
Am J Hematol. 99:727–738. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Tomas NM, Schnarre A, Dehde S, Lucas R,
Hermans-Borgmeyer I, Kretz O, Koellner SMS, Wiech T, Koch-Nolte F,
Seifert L, et al: Introduction of a novel chimeric active
immunization mouse model of PLA2R1-associated membranous
nephropathy. Kidney Int. 104:916–928. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Bonilla FA and Oettgen HC: Adaptive
immunity. J Allergy Clin Immunol. 125 (2 Suppl 2):S33–S40. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Ewanchuk BW and Yates RM: The phagosome
and redox control of antigen processing. Free Radic Biol Med.
125:53–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Perrin P, Jongsma ML, Neefjes J and Berlin
I: The labyrinth unfolds: Architectural rearrangements of the
endolysosomal system in antigen-presenting cells. Curr Opin
Immunol. 58:1–8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Rawlings DJ, Metzler G, Wray-Dutra M and
Jackson SW: Altered B cell signalling in autoimmunity. Nat Rev
Immunol. 17:421–436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Khan U and Ghazanfar H: T lymphocytes and
autoimmunity. Int Rev Cell Mol Biol. 341:125–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Mintz MA and Cyster JG: T follicular
helper cells in germinal center B cell selection and
lymphomagenesis. Immunol Rev. 296:48–61. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Aloui C, Prigent A, Sut C, Tariket S,
Hamzeh-Cognasse H, Pozzetto B, Richard Y, Cognasse F, Laradi S and
Garraud O: The signaling role of CD40 ligand in platelet biology
and in platelet component transfusion. Int J Mol Sci.
15:22342–22364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Karnell JL, Rieder SA, Ettinger R and
Kolbeck R: Targeting the CD40-CD40L pathway in autoimmune diseases:
Humoral immunity and beyond. Adv Drug Deliv Rev. 141:92–103. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Toubi E and Shoenfeld Y: The role of
CD40-CD154 interactions in autoimmunity and the benefit of
disrupting this pathway. Autoimmunity. 37:457–464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Komura K, Fujimoto M, Yanaba K, Matsushita
T, Matsushita Y, Horikawa M, Ogawa F, Shimizu K, Hasegawa M,
Takehara K and Sato S: Blockade of CD40/CD40 ligand interactions
attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
Ann Rheum Dis. 67:867–872. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Touma Z, Urowitz MB and Gladman DD:
Systemic lupus erythematosus: An update on current pharmacotherapy
and future directions. Expert Opin Biol Ther. 13:723–732. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Narain S and Furie R: Update on clinical
trials in systemic lupus erythematosus. Curr Opin Rheumatol.
28:477–487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Robles-Carrillo L, Meyer T, Hatfield M,
Desai H, Dávila M, Langer F, Amaya M, Garber E, Francis JL, Hsu YM
and Amirkhosravi A: Anti-CD40L immune complexes potently activate
platelets in vitro and cause thrombosis in FCGR2A transgenic mice.
J Immunol. 185:1577–1583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Visvanathan S, Daniluk S, Ptaszyński R,
Müller-Ladner U, Ramanujam M, Rosenstock B, Eleftheraki AG, Vinisko
R, Petříková A, Kellner H, et al: Effects of BI 655064, an
antagonistic anti-CD40 antibody, on clinical and biomarker
variables in patients with active rheumatoid arthritis: A
randomised, double-blind, placebo-controlled, phase IIa study. Ann
Rheum Dis. 78:754–760. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Jayne DR, Steffgen J, Romero-Diaz J,
Bajema I, Boumpas DT, Noppakun K, Amano H, Gomez HM, Satirapoj B,
Avihingsanon Y, et al: Clinical and biomarker responses to BI
655064, an antagonistic anti-CD40 antibody, in patients with active
lupus nephritis: A randomized, double-blind, placebo-controlled,
phase II trial. Arthritis Rheumatol. 75:1983–1993. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Sakamoto E, Katahira Y, Mizoguchi I,
Watanabe A, Furusaka Y, Sekine A, Yamagishi M, Sonoda J, Miyakawa
S, Inoue S, et al: Chemical- and drug-induced allergic,
inflammatory, and autoimmune diseases via haptenation. Biology
(Basel). 12:1232023.PubMed/NCBI
|
|
165
|
Rana PS, Murphy EV, Kort J and Driscoll
JJ: Road testing new CAR design strategies in multiple myeloma.
Front Immunol. 13:9571572022. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Hosseini A, Gharibi T, Marofi F, Babaloo Z
and Baradaran B: CTLA-4: From mechanism to autoimmune therapy. Int
Immunopharmacol. 80:1062212020. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Mikuš M, Goldštajn MŠ, Brlečić I, Dumančić
S, Laganà AS, Chiantera V, Vujić G and Ćorić M: CTLA4-linked
autoimmunity in the pathogenesis of endometriosis and related
infertility: A systematic review. Int J Mol Sci. 23:109022022.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Edner NM, Carlesso G, Rush JS and Walker
LSK: Targeting co-stimulatory molecules in autoimmune disease. Nat
Rev Drug Discov. 19:860–883. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Van Coillie S, Wiernicki B and Xu J:
Molecular and cellular functions of CTLA-4. Adv Exp Med Biol.
1248:7–32. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Hervey PS and Keam SJ: Abatacept.
BioDrugs. 20:53–62. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Esensten JH, Helou YA, Chopra G, Weiss A
and Bluestone JA: CD28 costimulation: From mechanism to therapy.
Immunity. 44:973–988. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Blair HA and Deeks ED: Abatacept: A review
in rheumatoid arthritis. Drugs. 77:1221–1233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Brunner HI, Wong R, Nys M, Kou TD,
Dominique A, Martini A, Lovell DJ and Ruperto N; Paediatric
Rheumatology International Trials Organisation (PRINTO) the
Pediatric Rheumatology Collaborative Study Group (PRCSG), :
Abatacept: A review of the treatment of polyarticular-course
juvenile idiopathic arthritis. Paediatr Drugs. 22:653–672. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Vicente-Rabaneda EF, Atienza-Mateo B,
Blanco R, Cavagna L, Ancochea J, Castañeda S and González-Gay MÁ:
Efficacy and safety of abatacept in interstitial lung disease of
rheumatoid arthritis: A systematic literature review. Autoimmun
Rev. 20:1028302021. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Lorenzetti R, Janowska I, Smulski CR,
Frede N, Henneberger N, Walter L, Schleyer MT, Hüppe JM, Staniek J,
Salzer U, et al: Abatacept modulates CD80 and CD86 expression and
memory formation in human B-cells. J Autoimmun. 101:145–152. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Gazeau P, Alegria GC, Devauchelle-Pensec
V, Jamin C, Lemerle J, Bendaoud B, Brooks WH, Saraux A, Cornec D
and Renaudineau Y: Memory B cells and response to abatacept in
rheumatoid arthritis. Clin Rev Allergy Immunol. 53:166–176. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Scarsi M, Paolini L, Ricotta D, Pedrini A,
Piantoni S, Caimi L, Tincani A and Airò P: Abatacept reduces levels
of switched memory B cells, autoantibodies, and immunoglobulins in
patients with rheumatoid arthritis. J Rheumatol. 41:666–672. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Furie R, Nicholls K, Cheng TT, Houssiau F,
Burgos-Vargas R, Chen SL, Hillson JL, Meadows-Shropshire S,
Kinaszczuk M and Merrill JT: Efficacy and safety of abatacept in
lupus nephritis: A twelve-month, randomized, double-blind study.
Arthritis Rheumatol. 66:379–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
ACCESS Trial Group, : Treatment of lupus
nephritis with abatacept: The abatacept and cyclophosphamide
combination efficacy and safety study. Arthritis Rheumatol.
66:3096–3104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Bocharnikov AV, Keegan J, Wacleche VS, Cao
Y, Fonseka CY, Wang G, Muise ES, Zhang KX, Arazi A, Keras G, et al:
PD-1hiCXCR5-T peripheral helper cells promote B cell responses in
lupus via MAF and IL-21. JCI Insight. 4:e1300622019. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Szabó K, Jámbor I, Pázmándi K, Nagy N,
Papp G and Tarr T: Altered circulating follicular T helper cell
subsets and follicular t regulatory cells are indicators of a
derailed B cell response in lupus, which could be modified by
targeting IL-21R. Int J Mol Sci. 23:122092022. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Giles JR, Kashgarian M, Koni PA and
Shlomchik MJ: B cell-specific MHC class II deletion reveals
multiple nonredundant roles for B cell antigen presentation in
murine lupus. J Immunol. 195:2571–2579. 2015. View Article : Google Scholar : PubMed/NCBI
|
